Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017

Skeletal-related events (SREs) may occur at the time of first diagnosis in 20–30% of lung cancer patients with bone metastases. Several clinical trials have shown that zoledronic acid (ZA) is effective for decreasing SREs. The main objective of the present study was to discuss clinical data of ZA an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahara, Yoshiro, Hosomi, Yukio, Shibuya, Masahiko, Mitsufuji, Hisashi, Katagiri, Masato, Naoki, Katsuhiko, Soejima, Kenzo, Nogami, Naoyuki, Nagase, Seisuke, Nishikawa, Masanori, Minato, Koichi, Takiguchi, Yuichi, Seki, Nobuhiko, Yamada, Kouzo, Seto, Takashi, Okamoto, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713944/
https://www.ncbi.nlm.nih.gov/pubmed/31475062
http://dx.doi.org/10.3892/mco.2019.1903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713944/
https://www.ncbi.nlm.nih.gov/pubmed/31475062
http://dx.doi.org/10.3892/mco.2019.1903

Ejemplares similares